METASHAPE PHARMA AG Press Releases - EIN Presswire - Press Release Distribution Service

Published on September 8, 2026 - 13:00 GMT

MetaShape Pharma to Showcase New Data and Strategic Updates at MedInvest and RESI Life Sciences Investor Conferences

Company to present new data supporting MS001 as a differentiated GLP-1 co-therapy addressing energy expenditure—the other side of the energy-balance equation RIEHEN, SWITZERLAND, September 8, 2026 /⁨EINPresswire.com⁩/ -- MetaShape Pharma AG (“MetaShape …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on June 9, 2026 - 11:30 GMT

MetaShape Pharma Presents New Data on MS 001 in Combination with GLP-1 Receptor Agonists at ADA 2026 Scientific Sessions

RIEHEN, BASEL, SWITZERLAND, June 9, 2026 /⁨EINPresswire.com⁩/ -- MetaShape Pharma AG (“MetaShape” or the “Company”), a biopharmaceutical company developing MS 001, a first-in-class oral small-molecule drug designed to amplify GLP-1 therapies, today …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on April 28, 2026 - 21:00 GMT

MetaShape Pharma Announces Presentations at the American Diabetes Association’s 2026 Scientific Sessions

New preclinical data on MS 001 in combination with semaglutide selected for ADA Late Breaking Poster Session and ePoster Theater RIEHEN, BASEL, SWITZERLAND, April 28, 2026 /⁨EINPresswire.com⁩/ -- MetaShape Pharma AG (“MetaShape”, or “the Company”), a …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 26, 2026 - 13:00 GMT

MetaShape Pharma Appoints World-Leading Bioenergetics Expert, Professor Shingo Kajimura, as Scientific Advisor

Physician-scientist and acclaimed adipose tissue biologist to advise on first-in-class, oral MS 001 for obesity. RIEHEN, BASEL, SWITZERLAND, February 26, 2026 /⁨EINPresswire.com⁩/ -- MetaShape Pharma AG (“MetaShape”, or “the Company”) today announced that …

Distribution channels: Healthcare & Pharmaceuticals Industry ...